odapipam has been researched along with benzofurans in 15 studies
Studies (odapipam) | Trials (odapipam) | Recent Studies (post-2010) (odapipam) | Studies (benzofurans) | Trials (benzofurans) | Recent Studies (post-2010) (benzofurans) |
---|---|---|---|---|---|
19 | 4 | 3 | 13,293 | 451 | 4,970 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 12 (80.00) | 18.2507 |
2000's | 3 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andersen, PH; Braestrup, C; Grønvald, FC; Guddal, E; Hansen, LB; Hohlweg, R; Nielsen, EB | 1 |
Hansen, KT; Stentoft, K | 1 |
Farde, L; Halldin, C; Karlsson, P; Sedvall, G; Sloth-Nielsen, M; Ynddal, L | 1 |
Farde, L; Foged, C; Halldin, C; Hansen, KT; Karlsson, P; Sedvall, G; Skrumsager, B; Swahn, CG | 1 |
Glenthøj, B | 1 |
Gerlach, J; Lublin, H; Mørkeberg, F | 1 |
Laihinen, AO; Lehikoinen, PK; Någren, KA; Oikonen, VJ; Rinne, JO; Rinne, UK; Ruotsalainen, UH; Ruottinen, HM | 1 |
Bolwig, TG; Glenthøj, B; Hemmingsen, R | 1 |
Farde, L; Foged, C; Grønvald, F; Hall, H; Halldin, C; Hansen, K; Karlsson, P; Sedvall, G; Swahn, CG | 1 |
Andersen, JV; Hansen, KT | 1 |
Gerlach, J; Hansen, L; Mørkeberg, F; Peacock, L | 1 |
Abi-Dargham, A; Anjilvel, S; Foged, C; Halldin, C; Hwang, DR; Kegeles, L; Laruelle, M; Lombardo, I; Mann, JJ; Parsey, R; Simpson, N; Van Heertum, R; Zea-Ponce, Y | 1 |
Aalto, S; Forssell, H; Hagelberg, N; Jääskeläinen, S; Luutonen, S; Någren, K; Rinne, JO; Scheinin, H; Taiminen, T | 1 |
Pascoe, PJ; Taylor, PM | 1 |
Aalto, S; Eskola, O; Forssell, H; Hagelberg, N; Jääskeläinen, SK; Någren, K; Rinne, JO; Scheinin, H; Taiminen, T | 1 |
4 trial(s) available for odapipam and benzofurans
Article | Year |
---|---|
Oral administration of NNC 756--a placebo controlled PET study of D1-dopamine receptor occupancy and pharmacodynamics in man.
Topics: Administration, Oral; Animals; Benzazepines; Benzofurans; Brain; Cross-Over Studies; Double-Blind Method; Male; Mice; Radioligand Assay; Receptors, Dopamine D1; Time Factors; Tomography, Emission-Computed | 1995 |
PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptor.
Topics: Adult; Animals; Benzazepines; Benzofurans; Brain; Brain Chemistry; Carbon Isotopes; Chromatography, High Pressure Liquid; Dopamine Antagonists; Humans; Ligands; Macaca fascicularis; Male; Receptors, Dopamine D1; Species Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1993 |
PET studies on dopamine D1 receptors in the human brain with carbon-11-SCH 39166 and carbon-11-NNC 756.
Topics: Adult; Aged; Benzazepines; Benzofurans; Brain; Carbon Radioisotopes; Dopamine Antagonists; Female; Humans; Kinetics; Male; Middle Aged; Organ Specificity; Parkinson Disease; Receptors, Dopamine D1; Reference Values; Tomography, Emission-Computed | 1994 |
Effects of dopamine antagonists on alfentanil-induced locomotor activity in horses.
Topics: Alfentanil; Analgesics, Opioid; Animals; Benzazepines; Benzofurans; Cross-Over Studies; Dopamine Antagonists; Dose-Response Relationship, Drug; Horses; Locomotion; Motor Activity; Pilot Projects; Prospective Studies; Salicylamides | 2003 |
11 other study(ies) available for odapipam and benzofurans
Article | Year |
---|---|
NNC-112, NNC-687 and NNC-756, new selective and highly potent dopamine D1 receptor antagonists.
Topics: Animals; Benzazepines; Benzofurans; Dopamine; Dopamine D2 Receptor Antagonists; In Vitro Techniques; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine D1; Serotonin | 1992 |
Characterization of benzazepine UDP-glucuronosyl-transferases in laboratory animals and man.
Topics: Aging; Animals; Benzazepines; Benzofurans; Detergents; Dogs; Dopamine Antagonists; Enzyme Induction; Female; Glucuronosyltransferase; Humans; Hydrogen-Ion Concentration; Male; Mice; Microsomes, Liver; Rabbits; Rats; Rats, Sprague-Dawley; Rats, Wistar; Sex Characteristics; Swine | 1995 |
Persistent vacuous chewing in rats following neuroleptic treatment: relationship to dopaminergic and cholinergic function.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Apomorphine; Benzazepines; Benzofurans; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dyskinesia, Drug-Induced; Haloperidol; Male; Parasympathetic Nervous System; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Scopolamine; Stereotyped Behavior | 1993 |
Long-term treatment with low doses of the D1 antagonist NNC 756 and the D2 antagonist raclopride in monkeys previously exposed to dopamine antagonists.
Topics: Animals; Basal Ganglia Diseases; Behavior, Animal; Benzazepines; Benzofurans; Cebus; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dyskinesia, Drug-Induced; Ergolines; Grooming; Hypnotics and Sedatives; Male; Motor Activity; Quinpirole; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides | 1994 |
Effects of chronic discontinuous and continuous treatment of rats with a dopamine D1 receptor antagonist (NNC-756).
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Benzofurans; Dopamine Antagonists; Drug Administration Schedule; Dyskinesia, Drug-Induced; Face; Jaw; Male; Rats; Rats, Wistar; Tongue; Tremor | 1993 |
[11C]NNC 687 and [11C]NNC 756, dopamine D-1 receptor ligands. Preparation, autoradiography and PET investigation in monkey.
Topics: Alkylation; Animals; Autoradiography; Benzazepines; Benzofurans; Brain; Carbon Radioisotopes; Cryoultramicrotomy; Humans; Macaca fascicularis; Male; Receptors, Dopamine D1; Tomography, Emission-Computed | 1993 |
Normal-phase liquid chromatography-particle-beam mass spectrometry in drug metabolism studies of the dopamine receptor antagonist Odapipam and the muscarine M1 receptor agonist Xanomeline.
Topics: Animals; Benzazepines; Benzofurans; Chromatography, High Pressure Liquid; Dopamine Antagonists; Male; Mass Spectrometry; Microsomes, Liver; Muscarinic Agonists; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Receptors, Muscarinic; Thiadiazoles | 1997 |
Chronic dopamine D1, dopamine D2 and combined dopamine D1 and D2 antagonist treatment in Cebus apella monkeys: antiamphetamine effects and extrapyramidal side effects.
Topics: Amphetamine; Animals; Arousal; Basal Ganglia Diseases; Benzazepines; Benzofurans; Cebus; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Interactions; Dyskinesia, Drug-Induced; Dystonia; Male; Motor Activity; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Stereotyped Behavior | 1999 |
PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756.
Topics: Amphetamine; Animals; Benzazepines; Benzofurans; Binding, Competitive; Brain Chemistry; Carbon Radioisotopes; Cerebral Cortex; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Antagonists; Female; Magnetic Resonance Imaging; Male; Papio; Raclopride; Receptors, Dopamine D1; Salicylamides; Thalamus; Tomography, Emission-Computed | 1999 |
Striatal dopamine D1 and D2 receptors in burning mouth syndrome.
Topics: Adult; Aged; Benzazepines; Benzofurans; Burning Mouth Syndrome; Carbon Radioisotopes; Chronic Disease; Corpus Striatum; Dopamine Antagonists; Humans; Middle Aged; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Tomography, Emission-Computed | 2003 |
Altered dopamine D2 receptor binding in atypical facial pain.
Topics: Aged; Benzazepines; Benzofurans; Carbon Radioisotopes; Dihydroxyphenylalanine; Dopamine Antagonists; Facial Pain; Humans; Middle Aged; Putamen; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Tomography, Emission-Computed | 2003 |